The data reported herein confirm that p700 retains its ability to target tumours and tumour vasculature via tyrosine kinase receptors when covalently cross-linked to PEGylated liposomes and that this clearly enhances uptake of Doxil into these cells. The gene discussed is NTRK1; the disease is neoplasm.